Half-year report · HY
3747.TEDINET S100Y4AG
Period2025-10-01 → 2026-03-31
Filed2026-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥869m | 2025-10-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥1.8bn | 2024-10-01 → 2025-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥863m | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Operating income | ¥536,000 | 2025-10-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥16m | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | −¥95m | 2025-10-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥213m | 2024-10-01 → 2025-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥85m | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥135m | 2025-10-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥38m | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥124m | 2025-10-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥145m | 2024-10-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥40m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥124m | 2025-10-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | −¥49m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥1.6bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥1.5bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥1.6bn | at 2025-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥367m | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥406m | at 2025-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥1.2bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.1bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥1.2bn | at 2025-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥691m | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥712m | at 2025-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥691m | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥712m | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥819m | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.0bn | at 2024-09-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥4m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥13m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥20m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥2m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥253m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥202m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥22m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥48m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥24m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥17.26 | 2025-10-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-20.2 | 2024-10-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.53 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 76.6% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.6% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.1% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-10-01 → 2026-03-31 | −¥173,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2025-10-01 → 2026-03-31 | −¥173,000 |
| Reconciling Itemsreconciling | segment profit | 2025-10-01 → 2026-03-31 | −¥164m |
| Business Solutionreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥119m |
| Business Solutionreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥119m |
| Business Solutionreportable segment | segment profit | 2025-10-01 → 2026-03-31 | −¥7m |
| Financial Solutionreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥694m |
| Financial Solutionreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥694m |
| Financial Solutionreportable segment | segment profit | 2025-10-01 → 2026-03-31 | ¥197m |
| Health Carereportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥56m |
| Health Carereportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥56m |
| Health Carereportable segment | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥173,000 |
| Health Carereportable segment | segment profit | 2025-10-01 → 2026-03-31 | −¥25m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-10-01 → 2026-03-31 | ¥869m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-10-01 → 2026-03-31 | ¥869m |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥173,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-10-01 → 2026-03-31 | ¥165m |
| Reconciling Itemsreconciling | revenue | 2024-10-01 → 2025-03-31 | −¥12,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2024-10-01 → 2025-03-31 | −¥12,000 |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-03-31 | −¥162m |
| Business Solutionreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥125m |
| Business Solutionreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥125m |
| Business Solutionreportable segment | segment profit | 2024-10-01 → 2025-03-31 | −¥21m |
| Financial Solutionreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥682m |
| Financial Solutionreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥682m |
| Financial Solutionreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥224m |
| Health Carereportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥55m |
| Health Carereportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥55m |
| Health Carereportable segment | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥12,000 |
| Health Carereportable segment | segment profit | 2024-10-01 → 2025-03-31 | −¥24m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-10-01 → 2025-03-31 | ¥863m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-10-01 → 2025-03-31 | ¥863m |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥12,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-10-01 → 2025-03-31 | ¥178m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 469
| Item | Context | Value | Unit |
|---|---|---|---|
| Cash and cash equivalents | Prior2YearInstant | 1024922000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 711547000 | JPY |
| Cash and cash equivalents | Prior1InterimInstant | 818576000 | JPY |
| Cash and cash equivalents | InterimInstant | 691406000 | JPY |
| Directors compensations sga | Prior1InterimDuration | 42654000 | JPY |
| Directors compensations sga | InterimDuration | 42164000 | JPY |
| Payroll and allowances sga | Prior1InterimDuration | 70006000 | JPY |
| Payroll and allowances sga | InterimDuration | 67035000 | JPY |
| Depreciation sga | Prior1InterimDuration | 847000 | JPY |
| Depreciation sga | InterimDuration | 714000 | JPY |
| Research and development expenses sga | Prior1InterimDuration | 13872000 | JPY |
| Research and development expenses sga | InterimDuration | 46349000 | JPY |
| Retirement benefit expenses sga | Prior1InterimDuration | 8614000 | JPY |
| Retirement benefit expenses sga | InterimDuration | 3614000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E05424-000FinancialSolutionReportableSegmentsMember | 682019000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E05424-000BusinessSolutionReportableSegmentsMember | 125383000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E05424-000HealthCareReportableSegmentsMember | 55394000 | JPY |
| Revenues from external customers | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 862797000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1InterimDuration | 862797000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E05424-000FinancialSolutionReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E05424-000BusinessSolutionReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E05424-000HealthCareReportableSegmentsMember | 12000 | JPY |
| Transactions with other segments | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 12000 | JPY |
| Transactions with other segments | Prior1InterimDuration_ReconcilingItemsMember | -12000 | JPY |
| Transactions with other segments | Prior1InterimDuration | － | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E05424-000FinancialSolutionReportableSegmentsMember | 682019000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E05424-000BusinessSolutionReportableSegmentsMember | 125383000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E05424-000HealthCareReportableSegmentsMember | 55407000 | JPY |
| Net sales | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 862810000 | JPY |
| Net sales | Prior1InterimDuration_ReconcilingItemsMember | -12000 | JPY |
| Net sales | Prior1InterimDuration | 862797000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E05424-000FinancialSolutionReportableSegmentsMember | 223767000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E05424-000BusinessSolutionReportableSegmentsMember | -21485000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E05424-000HealthCareReportableSegmentsMember | -24433000 | JPY |
| Operating income | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 177848000 | JPY |
| Operating income | Prior1InterimDuration_ReconcilingItemsMember | -161830000 | JPY |
| Operating income | Prior1InterimDuration | 16017000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E05424-000FinancialSolutionReportableSegmentsMember | 694164000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E05424-000BusinessSolutionReportableSegmentsMember | 118792000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E05424-000HealthCareReportableSegmentsMember | 55865000 | JPY |
| Revenues from external customers | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 868821000 | JPY |
| Revenues from external customers | InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | InterimDuration | 868821000 | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E05424-000FinancialSolutionReportableSegmentsMember | － | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E05424-000BusinessSolutionReportableSegmentsMember | － | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E05424-000HealthCareReportableSegmentsMember | 173000 | JPY |
| Transactions with other segments | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 173000 | JPY |
| Transactions with other segments | InterimDuration_ReconcilingItemsMember | -173000 | JPY |
| Transactions with other segments | InterimDuration | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |